Prevalence of extended-spectrum β-lactamases in South America

Kliebe, 1985, Evolution of plasmid-coded resistance to broad-spectrum cephalosporins, Antimicrob Agents Chemother, 28, 302, 10.1128/AAC.28.2.302 Knothe, 1983, Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens, Infection, 11, 315, 10.1007/BF01641355 Brun-Buisson, 1987, Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae, Lancet, 2, 302, 10.1016/S0140-6736(87)90891-9 Radice, 2002, Early dissemination of CTX-M-derived enzymes in South America, Antimicrob Agents Chemother, 46, 602, 10.1128/AAC.46.2.602-604.2002 Ilanberge, 1992, Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups, JAMA, 281, 67 Paterson, 2005, Extended-spectrum beta-lactamases: a clinical update, Clin Microbiol Rev, 18, 657, 10.1128/CMR.18.4.657-686.2005 Casellas, 1999, South America: a different continent, different ESBLs, J Antimicrob Chemother, 44, 16 Quinteros, 2003, Extended-spectrum beta-lactamases in enterobacteriaceae in Buenos Aires, Argentina, public hospitals, Antimicrob Agents Chemother, 47, 2864, 10.1128/AAC.47.9.2864-2867.2003 Sader, 2006, The SENTRY Participants Group (Latin America). SENTRY Antimicrobial Surveillance Program Report: Latin American and Brazilian Results for 1997 through 2001, Braz J Infect Dis, 8, 25, 10.1590/S1413-86702004000100004 Winokur, 2001, Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region, Clin Infect Dis, 32, S94, 10.1086/320182 Turner, 1999, The MYSTIC (meropenem yearly susceptibility test information collection) programme, Int J Antimicrob Agents, 13, 117, 10.1016/S0924-8579(99)00115-6 Mendes, 2000, Evaluation of the in vitro activity of 9 antimicrobials against bacterial strains isolated from patients in intensive care units in brazil: MYSTIC Antimicrobial Surveillance Program, Braz J Infect Dis, 4, 236 Otman, 2002, An outbreak of extended-spectrum beta-lactamase-producing Klebsiella species in a neonatal intensive care unit in Brazil, Infect Control Hosp Epidemiol, 23, 8, 10.1086/503447 Pfaller, 1999, Multicenter evaluation of the antimicrobial activity for six broad-spectrum beta-lactams in Venezuela: comparison of data from 1997 and 1998 using the Etest method. Venezuelan Antimicrobial Resistance Study Group, Diagn Microbiol Infect Dis, 35, 153, 10.1016/S0732-8893(99)00071-1 Pfaller, 1999, Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia: comparison of data from 1997 and 1998 using the Etest method. The Colombian Antimicrobial Resistance Study Group, Diagn Microbiol Infect Dis, 35, 235, 10.1016/S0732-8893(99)00077-2 Sader, 2000, Prevalence of antimicrobial resistance among respiratory tract isolates in Latin America: results from SENTRY antimicrobial surveillance program (1997–98), Braz J Infect Dis, 4, 245 Sader, 1998, Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: analysis of results from the SENTRY Antimicrobial Surveillance Program (1997). SENTRY Latin America Study Group, Diagn Microbiol Infect Dis, 32, 289, 10.1016/S0732-8893(98)00124-2 Miranda, 2006, Resistencia a antimicrobianos en bacilos Gram negativos aislados en unidades de cuidado intensivo en hospitales de Colombia, WHONET 2003, 2004 y 2005, Biomedica, 26, 424, 10.7705/biomedica.v26i3.361 Motta, 2003, Plasmid-mediated extended-spectrum beta-lactamase-producing strains of Enterobacteriaceae isolated from diabetes foot infections in a Brazilian diabetic center, Braz J Infect Dis, 7, 129, 10.1590/S1413-86702003000200006 Villegas, 2004, Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals, Diagn Microbiol Infect Dis, 49, 217, 10.1016/j.diagmicrobio.2004.03.001 Paterson, 2003, Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamases, Antimicrob Agents Chemother, 47, 3554, 10.1128/AAC.47.11.3554-3560.2003 Govinden, 2007, Geographical evolution of the CTX-M β-lactamase—an update, Afr J Biotechnol, 6, 831 Jacoby, 2005, The new beta-lactamases, N Engl J Med, 352, 380, 10.1056/NEJMra041359 Casellas, 2003, Argentinean collaborative multicenter study on the in vitro comparative activity of piperacillin–tazobactam against selected bacterial isolates recovered from hospitalized patients, Diagn Microb Infect Dis, 47, 247, 10.1016/S0732-8893(03)00131-7 Ben, 1988, Synergy between clavulanic acid and newer beta-lactams on nine clinical isolates of Klebsiella pneumoniae, Escherichia coli and Salmonella typhimurium resistant to third-generation cephalosporins, J Antimicrob Chemother, 21, 263, 10.1093/jac/21.2.263 Jarlier, 1988, Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns, Rev Infect Dis, 10, 867, 10.1093/clinids/10.4.867 Casellas, 1989, Incidence of strains producing extended spectrum beta-lactamases in Argentina, Infection, 17, 434, 10.1007/BF01645567 Bauernfeind, 1992, A new plasmidic cefotaximase from patients infected with Salmonella typhimurium, Infection, 20, 158, 10.1007/BF01704610 Bonnet, 2001, Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240->Gly, Antimicrob Agents Chemother, 45, 2269, 10.1128/AAC.45.8.2269-2275.2001 Pallecchi, 2007, Rapid dissemination and diversity of CTX-M extended-spectrum beta-lactamase genes in commensal Escherichia coli from healthy children from low-resource settings of Latin America, Antimicrob Agents Chemother, 51, 2720, 10.1128/AAC.00026-07 Bauernfeind, 1996, Sequences of beta-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other beta-lactamases, Antimicrob Agents Chemother, 40, 509, 10.1128/AAC.40.2.509 Bonnet, 2000, A novel CTX-M beta-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil, Antimicrob Agents Chemother, 44, 1936, 10.1128/AAC.44.7.1936-1942.2000 Villegas, 2004, CTX-M-12 beta-lactamase in a Klebsiella pneumoniae clinical isolate in Colombia, Antimicrob Agents Chemother, 48, 629, 10.1128/AAC.48.2.629-631.2004 Kariuki, 2001, Molecular characterization of a novel plasmid-encoded cefotaximase (CTX-M-12) found in clinical Klebsiella pneumoniae isolates from Kenya, Antimicrob Agents Chemother, 45, 2141, 10.1128/AAC.45.7.2141-2143.2001 Pallecchi, 2004, Detection of CTX-M-type beta-lactamase genes in fecal Escherichia coli isolates from healthy children in Bolivia and Peru, Antimicrob Agents Chemother, 48, 4556, 10.1128/AAC.48.12.4556-4561.2004 Nordmann, 1994, Sequence analysis of PER-1 extended-spectrum beta-lactamase from Pseudomonas aeruginosa and comparison with class A beta-lactamases, Antimicrob Agents Chemother, 38, 104, 10.1128/AAC.38.1.104 Bauernfeind, 1996, Characterization of beta-lactamase gene blaPER-2, which encodes an extended-spectrum class A beta-lactamase, Antimicrob Agents Chemother, 40, 616, 10.1128/AAC.40.3.616 Rossi, 1995, Non-typhoid Salmonella spp. resistant to cefotaxime, J Antimicrob Chemother, 36, 697, 10.1093/jac/36.4.697 Petroni, 2002, Plasmidic extended-spectrum beta-lactamases in Vibrio cholerae O1 El Tor isolates in Argentina, Antimicrob Agents Chemother, 46, 1462, 10.1128/AAC.46.5.1462-1468.2002 Rodriguez, 2005, Enzymatic resistance to beta lactam antibiotics within the genus Proteus and evaluation of Proteus mirabilis phenotypes and genotypes for resistance to third- and fourth-generation cephalosporins, Enferm Infecc Microbiol Clin, 23, 122 Poirel, 2000, Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae, Antimicrob Agents Chemother, 44, 622, 10.1128/AAC.44.3.622-632.2000 Bonnet, 2000, A novel class A extended-spectrum beta-lactamase (BES-1) in Serratia marcescens isolated in Brazil, Antimicrob Agents Chemother, 44, 3061, 10.1128/AAC.44.11.3061-3068.2000 Mirelis, 2003, Community transmission of extended-spectrum beta-lactamase, Emerg Infect Dis, 9, 1024, 10.3201/eid0908.030094 Colodner, 2004, Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients, Eur J Clin Microbiol Infect Dis, 23, 163, 10.1007/s10096-003-1084-2 Minarini, 2007, Prevalence of community-occurring extended spectrum beta-lactamase-producing Enterobacteriaceae in Brazil, Curr Microbiol, 54, 335, 10.1007/s00284-006-0307-z